Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.
about
Transplantation Tolerance Induction: Cell Therapies and Their MechanismsEvolution of animal models in cancer vaccine developmentEfficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Autoimmune effector memory T cells: the bad and the goodUnifying roles for regulatory T cells and inflammation in cancer.ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult miceHepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in miceDNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in miceOncoantigens for an immune prevention of cancer.Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer.Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors.Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancerInflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice.DC targeting DNA vaccines induce protective and therapeutic antitumor immunity in mice.The impact of regulatory T cells on carcinogen-induced sarcogenesisEffective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells.Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancerFrom cancer immunosurveillance to cancer immunotherapy.Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.HER-2/neu as a target for cancer vaccines.DNA vaccination against oncoantigens: A promise.Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive CancersHigh IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8⁺ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice.Development of metastatic HER2(+) breast cancer is independent of the adaptive immune system.
P2860
Q26751022-9A44ED7A-4029-402D-B1DA-576BFF43CEACQ28080739-5C2F4B06-4A27-463F-830D-C5356F917259Q33577507-F38D37C8-881E-43CA-B842-FEF2C4278BC8Q33786788-184E4EF1-ADB6-4F6F-848E-D1E46F87CBECQ33794691-932337A0-CBA1-48A7-BF88-B1F8C0E63BCDQ33796559-EC0FB52B-D725-42F9-BA1A-A68A22DD7A9DQ34598522-F6B74713-D531-48D7-A1CB-6FA36A9BFBCCQ34813756-41443862-6585-4F97-8426-60FDB1CF258FQ34939255-A58E5AA1-C8FA-4BBE-98D3-2EA84FF18A8DQ35232253-9FCBF8C4-F077-4763-B053-E2F71BDBAF03Q35607012-7F840CD1-D0E5-4CE6-BAE9-6490B9FBC7D8Q35851930-0DF660EC-D3B3-44BA-9097-9FF940A59E6EQ36007167-6AAF7D2D-B7C0-4925-83E7-A71CEDA78076Q36073267-E4F775E0-1628-45BE-B9F7-BCFD3EE2B122Q36393263-D278210C-3290-4312-BA42-76A5178399C4Q36411564-5430FEED-27BA-4E0B-B6C0-44A8866E0522Q36609617-F5490EAD-893D-4CC3-BE9C-EBEC8B8B9E74Q36698273-8439D5D4-700B-4F46-B53C-884835B43DB1Q36821263-D037E847-20A2-4AC4-8031-55D8CB2C2C79Q36990588-C61D641D-934B-4DCC-8810-5963AC84F36DQ37000546-97AD8E43-2CD6-4BC4-ABCD-C0D555FD624AQ37137404-97E7BBE1-40A0-444F-9AD4-25D885574786Q37289084-2112ED50-8FB5-49A4-8001-51B9C79E43CCQ37773255-DA26535F-7C71-4334-A90B-2B854D3D202DQ38022032-C1E86D78-6DCA-4528-9A53-EB67B3C79DC2Q40674386-6E001E9C-7E2A-4080-BC3C-D8073355E845Q41472534-803377A6-8EC1-4301-A22F-FF26E4C63673Q53248364-DE0FC388-C06B-4C49-89DE-6F08AF5DAF74Q53255022-DB79197D-953A-4F04-B3CF-99E71C87A0A3
P2860
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@en
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@nl
type
label
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@en
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@nl
prefLabel
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@en
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@nl
P2093
P1433
P1476
Immunosurveillance of Erbb2 ca ...... ulatory T-cell self-tolerance.
@en
P2093
Claudia Curcio
Elena Ambrosino
Guido Forni
Michela Spadaro
Piero Musiani
Wei-Zen Wei
P304
P356
10.1158/0008-5472.CAN-06-1432
P407
P577
2006-08-01T00:00:00Z